- Home
- BPOP vs MDGL Comparison
BPOP vs MDGL Comparison
Compare BPOP & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | MDGL |
|---|---|---|
| Founded | 1893 | 2011 |
| Country | United States | United States |
| Employees | 37 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.5B |
| IPO Year | 1999 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BPOP | MDGL |
|---|---|---|
| Price | $159.09 | $437.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 19 |
| Target Price | $195.20 | ★ $685.78 |
| AVG Volume (30 Days) | ★ 413.1K | 262.9K |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.28% | N/A |
| EPS Growth | ★ 43.69 | N/A |
| EPS | ★ 8.13 | N/A |
| Revenue | ★ $756,100,000.00 | $180,133,000.00 |
| Revenue This Year | $8.13 | $59.57 |
| Revenue Next Year | $3.73 | $38.84 |
| P/E Ratio | $19.36 | ★ N/A |
| Revenue Growth | ★ 16.00 | N/A |
| 52 Week Low | $108.74 | $393.61 |
| 52 Week High | $179.24 | $615.00 |
Technical Indicators
Market Signals| Indicator | BPOP | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 48.94 | 29.07 |
| Support Level | $158.01 | $416.21 |
| Resistance Level | $160.06 | $546.29 |
| Average True Range (ATR) | 3.06 | 18.02 |
| MACD | 0.73 | -1.58 |
| Stochastic Oscillator | 63.53 | 1.57 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.